Potential Drug Interaction Between Warfarin, COVID-19 Treatment Reported
A probable drug interaction was observed in 2 patients taking warfarin who were initiated on remdesivir and dexamethasone for the treatment of COVID-19.
A probable drug interaction was observed in 2 patients taking warfarin who were initiated on remdesivir and dexamethasone for the treatment of COVID-19.
Ryplazim is supplied in a 50mL single-dose vial containing 68.8mg of plasminogen as a lyophilized powder for intravenous use after reconstitution.
The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 4WHILM trial.
The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications.
Dr Charles Raison, the Director of Clinical Research at the Usona Institute and Professor in the Department of Psychiatry at the University of Wisconsin–Madison, talks to…
Distribution will end on June 1, 2024.
Each Ingrezza Sprinkle capsule contains oral granules consisting of valbenazine, a vesicular monoamine transporter 2 inhibitor.
Dr Charles Raison, the Director of Clinical Research at the Usona Institute and Professor in the Department of Psychiatry at the University of Wisconsin–Madison, talks to…
Beqvez is a one-time AAV-based gene therapy designed to introduce in the transduced cells a functional copy of the FIX gene encoding a high-activity FIX…
MamaLift Plus is intended as an adjunct to clinician-managed outpatient care to provide neurobehavioral interventions to patients 22 years of age and older with mild…
Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist.